Wobenzym Table n / an kish.rastv. 40 pc

$10.82

Wobenzym Table n / an kish.rastv. 40 pc

Quantity:

Description

Composition
Active substance:
1 tablet contains:
Pancreatin 300 Prot. U (100.0 mg), papain 90 U FIP. (18.00 mg) rutoside trihydrate 50.00 mg, bromelain 225 FIP U. (45.00 mg), 360 FIP U trypsin. (12.00 mg), 34 FIP U lipase. (10.00 mg), 50 FIP U amylase. (10.00 mg), 300 FIP U chymotrypsin. (0.75 mg).
Excipients:
149 mg of lactose monohydrate, pregelatinized starch 31.3 mg magnesium stearate 6.00 mg, 6.00 mg stearic acid, colloidal anhydrous silica 3.00 mg Talc 1.50 mg.
sheath:
11.9 mg film coating (methacrylic acid-methyl methacrylate (1: 1) 11.9 mg sodium lauryl sulphate 0.04 mg) talc 4.23 mg Macrogol 6000 0.67 mg, 1.20 mg of triethyl citrate, stearic acid 6.00 mg, 12.8 mg colored coating (hypromellose 3.20 mg hydroxypropylcellulose 3.83 mg microcrystalline cellulose 1.60 mg, glycerol 0.64 mg talc 1.92 mg titanium dioxide 0.38 mg , dye ponceau 4R (E 124) 0.38 mg, dye yellow orange S (E 110) 0.83 mg).
Description:
Round, biconvex tablets with a smooth surface, from red-orange to red color with a characteristic smell.
Product form:
Tablets enteric coated.
20 tablets in PVC / PE / PVDC / Aluminum blisters.
2, 5 or 10 blisters together with instructions for use in a cardboard pack.
800 tablets into bottles of high density polyethylene. 1 bottle together with instructions for use in a cardboard pack.
Contraindications
Individual intolerance to the drug. Diseases associated with increased likelihood of bleeding (hemophilia, thrombocytopenia, and others.). Hemodialysis. Children up to age 5 years.
Indications
It is used in the treatment of the following diseases:
Angiology: thrombophlebitis, treatment postthrombophlebitic disease and acute superficial vein thrombophlebitis, endarteritis obliterans and atherosclerosis lower extremity arteries, the prevention of recurrent phlebitis, lymphoedema.
Urology: cystitis, cystopyelitis, prostatitis, infections, sexually transmitted diseases.
Gynecology: chronic genital infections, adnexitis, gestosis, mastitis, to reduce the frequency and severity of side effects of hormone replacement therapy.
Cardiology: angina, subacute phase of myocardial infarction (for improving the rheological properties of the blood).
Pulmonology: sinusitis, bronchitis, pneumonia.
Gastroenterology: pancreatitis, hepatitis.
Nephrology: pyelonephritis, glomerulonephritis.
Endocrinology: diabetic angiopathy, diabetic retinopathy, autoimmune thyroiditis.
Rheumatology: Rheumatoid arthritis, reactive arthritis, Bechterew’s disease.
Dermatology: atopic dermatitis, acne.
Surgery: prevention and treatment of postoperative complications (inflammation, thrombosis, edema), adhesive disease, post-traumatic and lymphatic edema, plastic and reconstructive surgery.
Trauma: trauma, fractures, distortion, damaged ligaments, bruises, chronic post-traumatic processes, soft tissue inflammation, burns, injuries in sports medicine.
Neurology: multiple sclerosis.
Pediatrics: atopic dermatitis, infectious and inflammatory airway diseases (inflammation of the upper and lower respiratory tract infections, pneumonia), juvenile rheumatoid arthritis, prevention and treatment of postoperative complications (suppuration and poor wound healing, the formation of adhesions, local edema).
Ophthalmology: Uveitis, iridocyclitis, hemophthalmus, diabetic retinopathy, ophthalmosurgery.
Prevention: microcirculation disorders, poststressornyh violations and failure of adaptation mechanisms. Preventing side effects of hormone replacement therapy, hormonal contraception. In surgical interventions for the prevention of infectious complications and adhesive disease.
Wobenzym is recommended for the prevention of infectious complications and improve quality of life during chemotherapy or radiation therapy. Prevention of viral infections and their complications.
Interaction with other drugs
incompatibilities have not been described, when taken concomitantly with other drugs Wobenzym.
Overdose
Overdoses of the drug is unknown.
pharmachologic effect
Pharmacological group:
Anti-inflammatory, immunomodulatory agent.
Pharmacological properties:
Vobenzim represents a combination of natural enzymes of vegetable and animal origin. In the body, the enzymes are absorbed in the small intestine by resorption of intact molecules and binding to blood transport proteins into the bloodstream. Subsequently enzymes, migrating at bloodstream and accumulate in pathological process zone, exert immunomodulatory, antiinflammatory, fibrinolytic, anti, and vtorichnoanalgeziruyuschee antiplatelet action.
Wobenzym has a positive effect on the course of the inflammatory process, limits the pathological manifestations of autoimmune and immune processes, positively influences the performance of immunological reactivity. Performs stimulation and regulation of functional activity of monocytes, macrophages, natural killer cells, stimulates antitumor immunity, cytotoxic T lymphocytes, phagocytic activity of cells.
Under the influence Wobenzym reduced number of circulating immune complexes and excretion occurs membrane deposits of immune complexes from the tissues.
Wobenzym reduces the interstitial infiltration of plasma cells. Increases elimination protein detritus and fibrin deposits in the area of ​​inflammation, accelerates the lysis of toxic metabolic products and necrotic tissue. Vobenzim normalizes vascular permeability walls promotes faster resorption of edema and hematoma.
Vobenzim reduces the concentration of thromboxane and platelet aggregation. It regulates adhesion of blood cells increases the capacity of erythrocytes to change its shape by adjusting their ductility, and normalizes the number of normal discocytes and reduces the total number of activated forms of platelets, and normalizes blood viscosity, reduces the total number of microaggregates, thereby improving microcirculation and blood rheology, and supply of tissues oxygen and nutrients.
Vobenzim reduces the severity of side effects associated with the administration of hormonal preparations (hypercoagulation, etc.).
Vobenzim normalizes lipid metabolism, reduces the endogenous synthesis of cholesterol, increases the content of high density lipoprotein, reduce the level of atherogenic lipids, improves absorption of polyunsaturated fatty acids.
Vobenzim increases plasma concentrations of antibiotics and the inflammation, thus increasing the efficiency of their use. Simultaneously enzymes reduce unwanted side effects of antibiotic therapy (dysbiosis), by improving the ecology.
Wobenzym regulates the mechanisms of nonspecific protection (of interferon), thereby demonstrating antiviral and antimicrobial action.
Pregnancy and breast-feeding
Pregnancy and breast-feeding is not a contraindication for the use of the drug, however, pregnant women should take Wobenzym under medical supervision.
Conditions of supply of pharmacies
Without a prescription.
side effects
Wobenzym is well tolerated by patients. In most cases, side effects, withdrawal, addiction was not observed even after prolonged treatment with high doses. In some cases, there are minor changes in consistency and the smell of feces, skin rash as urticaria which extend at lower dose or cancellation.
In case of other adverse reactions not mentioned in the manual, it is recommended to cancel taking the drug and consult a doctor.
special instructions
In the case of infectious processes Wobenzym not a substitute for antibiotics, but increases their efficiency, increasing the concentration in the blood plasma and inflammation.
It should be borne in mind that at the beginning of the drug can worsen symptoms in such cases, treatment should not be interrupted, and a temporary reduction in dose is recommended. The drug is not doping.
Effects on ability to drive a vehicle, the mechanism
The drug has no adverse effect on the ability to drive and do work, requiring a high rate of mental and physical reactions.
Storage conditions
At a temperature of not higher than 25 C.
Keep out of the reach of children!.
Dosing and Administration
The tablets should be taken orally, not less than 30 minutes before a meal, without chewing, drinking water (200 mL).
Adults
Depending on the activity and severity of disease vobenzim take a dose of 3 to 10 tablets 3 times a day. In the first three days of dosing recommended dosage is 3 tablets 3 times a day.
When the average activity vobenzim diseases administered in a dose of 5-7 tablets three times a day for 2 weeks. Subsequently Wobenzym dose should be reduced to 3-5 tablets three times a day, the course of 2 weeks.
At high disease activity vobenzim administered in a dose of 7-10 tablets 3 times a day for 2-3 weeks. Subsequently, the dosage Wobenzym reduced to 5 tablets three times a day, the rate of 2-3 months.
In chronic diseases vobenzim long current can be applied by indications rates from 3 to 6 months or more.
In order to increase the effectiveness of antibiotics and the prevention of dysbiosis, Wobenzym should be used throughout the course of antibiotic therapy at a dose of 5 tablets 3 times a day. After the termination of a course of antibiotics to restore microflora (biocenosis), the intestines Wobenzym should be administered 3 tablets 3 times a day for 2 weeks.
As treatment “cover” during the chemotherapy and radiotherapy vobenzim be applied in a dose of 5 tablets three times a day until the completion of a course of chemotherapy and radiotherapy; for the prevention of infectious complications, improve the portability of basic therapy and quality of life.
In applying Wobenzym prophylactic dose is 3 tablets 3 times a day, with course of 1.5 months repeating 2-3 times per year.
Children
Children from 5 to 12 years – 6 kg child 1 tablet per day. With 12 years under the scheme for adults. The dosage and duration of treatment depend on the severity of the disease and are determined by your doctor.
Information
Appearance may differ from that depicted in the picture. There are contraindications. You need to read the manual or consult with a specialist

Additional information

Weight0.100 kg
Manufacturer

MUKOS PHARMA

There are no reviews yet.

Add your review